Kim, T.;                     Joo, D.-H.;                     Lee, S.W.;                     Lee, J.;                     Lee, S.J.;                     Kang, J.    
        Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19. J. Clin. Med. 2022, 11, 1412.
    https://doi.org/10.3390/jcm11051412
    AMA Style
    
                                Kim T,                                 Joo D-H,                                 Lee SW,                                 Lee J,                                 Lee SJ,                                 Kang J.        
                Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19. Journal of Clinical Medicine. 2022; 11(5):1412.
        https://doi.org/10.3390/jcm11051412
    
    Chicago/Turabian Style
    
                                Kim, Taeyun,                                 Dong-Hyun Joo,                                 Seung Woo Lee,                                 Jaejun Lee,                                 Sang Jin Lee,                                 and Jihun Kang.        
                2022. "Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19" Journal of Clinical Medicine 11, no. 5: 1412.
        https://doi.org/10.3390/jcm11051412
    
    APA Style
    
                                Kim, T.,                                 Joo, D.-H.,                                 Lee, S. W.,                                 Lee, J.,                                 Lee, S. J.,                                 & Kang, J.        
        
        (2022). Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19. Journal of Clinical Medicine, 11(5), 1412.
        https://doi.org/10.3390/jcm11051412